• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Monitoring platelet GP IIb/IIIa antagonist therapy.

作者信息

Coller B S

机构信息

Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.

出版信息

Circulation. 1998;97(1):5-9. doi: 10.1161/01.cir.97.1.5.

DOI:10.1161/01.cir.97.1.5
PMID:9443422
Abstract
摘要

相似文献

1
Monitoring platelet GP IIb/IIIa antagonist therapy.监测血小板糖蛋白IIb/IIIa拮抗剂治疗。
Circulation. 1998;97(1):5-9. doi: 10.1161/01.cir.97.1.5.
2
Monitoring platelet GP IIb/IIIa [corrected] antagonist therapy.监测血小板糖蛋白IIb/IIIa拮抗剂治疗。
Circulation. 1997 Dec 2;96(11):3828-32.
3
Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction.经皮冠状动脉介入治疗中与静脉推注相比，血小板抑制和糖蛋白 IIb/IIIa 受体占有率与冠状动脉内应用阿昔单抗在 ST 段抬高型心肌梗死患者中的关系。
Clin Res Cardiol. 2012 Feb;101(2):117-24. doi: 10.1007/s00392-011-0372-6. Epub 2011 Oct 21.
4
Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy.在接受抗血小板糖蛋白IIb/IIIa治疗的经皮冠状动脉腔内血管成形术患者中，使用改良全血凝集仪快速评估血小板功能。
Circulation. 1997 Dec 2;96(11):3860-6. doi: 10.1161/01.cir.96.11.3860.
5
Therapeutic heparin concentrations augment platelet reactivity: implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab.治疗性肝素浓度会增强血小板反应性：对糖蛋白IIb/IIIa拮抗剂阿昔单抗的药理学评估的启示。
Am Heart J. 2000 Apr;139(4):696-703. doi: 10.1016/s0002-8703(00)90050-4.
6
Primary and secondary safety endpoints from IMPACT II. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.
Am J Cardiol. 1997 Aug 18;80(4A):29B-33B. doi: 10.1016/s0002-9149(97)00574-2.
7
Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
Am Heart J. 2006 Nov;152(5):876-81. doi: 10.1016/j.ahj.2006.04.035.
8
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.冠状动脉支架置入术及辅助性血小板糖蛋白IIb/IIIa抑制在复杂动脉粥样硬化病变中的显著益处。
Circulation. 2000 Jul 4;102(1):28-34. doi: 10.1161/01.cir.102.1.28.
9
Differential dose-response to oral xemilofiban after antecedent intravenous abciximab. Administration for complex coronary intervention.
Circulation. 1996 Sep 1;94(5):906-10. doi: 10.1161/01.cir.94.5.906.
10
Oral blockade of the platelet glycoprotein IIb/IIIa receptor: fact or fancy?口服阻断血小板糖蛋白IIb/IIIa受体：是事实还是幻想？
Am Heart J. 1999 Jul;138(1 Pt 2):S39-46. doi: 10.1053/hj.1999.v138.99080.

引用本文的文献

1
Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.抗血小板治疗：糖蛋白 IIb-IIIa 拮抗剂。
Br J Clin Pharmacol. 2011 Oct;72(4):672-82. doi: 10.1111/j.1365-2125.2010.03879.x.
2
Translational research: forging a new cultural identity.转化医学研究：塑造一种新的文化身份。
Mt Sinai J Med. 2008 Oct;75(5):478-87. doi: 10.1002/msj.20064.
3
Abciximab and left ventricular thrombus formation in early period of acute myocardial infarction treated with successful primary stenting.替罗非班和急性心肌梗死后早期行直接经皮冠状动脉介入治疗并发左心室血栓形成。
J Thromb Thrombolysis. 2009 May;27(4):447-52. doi: 10.1007/s11239-008-0226-x. Epub 2008 May 4.
4
Thromboelastography detects inadequate response to abciximab therapy during stent-assisted cerebral aneurysm coil embolization complicated by stroke.血栓弹力图检测显示，在支架辅助脑动脉瘤弹簧圈栓塞术并发卒中时，对阿昔单抗治疗反应不足。
Neurocrit Care. 2006;4(1):32-4. doi: 10.1385/NCC:4:1:032.
5
Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty.口服血小板糖蛋白IIb/IIIa受体拮抗剂来氟达非班在择期血管成形术的稳定型冠心病患者中的药效学和安全性
Heart. 2001 Apr;85(4):444-50. doi: 10.1136/heart.85.4.444.
6
Glycoprotein IIb/IIIa receptor antagonists: clinical pharmacology in cardiovascular diseases of aging.糖蛋白IIb/IIIa受体拮抗剂：衰老心血管疾病中的临床药理学
Drugs Aging. 1999 Sep;15(3):207-18. doi: 10.2165/00002512-199915030-00004.
7
Efficacy of abciximab induced platelet blockade using a rapid point of care assay.
J Thromb Thrombolysis. 1999 Jun;7(3):265-76. doi: 10.1023/a:1008931126871.
8
Abciximab. An updated review of its use in ischaemic heart disease.阿昔单抗。关于其在缺血性心脏病中应用的最新综述。
Drugs. 1998 Oct;56(4):629-65. doi: 10.2165/00003495-199856040-00014.